Tylenol and Deafness neurosensory - a phase IV clinical study of FDA data
Deafness neurosensory is found among people who take Tylenol, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Tylenol and have Deafness neurosensory. It is created by eHealthMe based on reports of 185,254 people who have side effects when taking Tylenol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
185,254 people reported to have side effects when taking Tylenol.
Among them, 379 people (0.2%) have Deafness neurosensory.
What is Tylenol?
Tylenol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 189,583 Tylenol users for its effectiveness, alternative drugs and more.
What is Deafness neurosensory?
Deafness neurosensory is found to be associated with 1,422 drugs and 869 conditions by eHealthMe.
Number of Tylenol and Deafness neurosensory reports submitted per year:
Time on Tylenol when people have Deafness neurosensory *:
Gender of people who have Deafness neurosensory when taking Tylenol*:
Age of people who have Deafness neurosensory when taking Tylenol *:
Common drugs people take besides Tylenol *:
Common side effects people have besides Deafness neurosensory *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Tylenol and have Deafness neurosensory?Check whether Deafness neurosensory is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Deafness neurosensory and when was it recovered:
Expand to all the drugs that have ingredients of acetaminophen:
Alternative drugs to, pros and cons of Tylenol:
- Tylenol (189,583 reports)
Common Tylenol side effects:
- Fatigue (feeling of tiredness): 19,344 reports
- Drug ineffective: 18,707 reports
- Pain: 16,419 reports
- Headache (pain in head): 15,040 reports
- Diarrhea: 13,399 reports
- Breathing difficulty: 12,950 reports
- Joint pain: 11,757 reports
- Weakness: 11,540 reports
Browse all side effects of Tylenol:a b c d e f g h i j k l m n o p q r s t u v w x y z
Deafness neurosensory treatments and more:
- Deafness neurosensory (4,111 reports)
COVID vaccines that are related to Deafness neurosensory:
- Deafness neurosensory in Moderna COVID Vaccine
- Deafness neurosensory in Pfizer BioNTech Covid Vaccine
- Deafness neurosensory in Johnson and Johnson Covid Vaccine
Common drugs associated with Deafness neurosensory:
- Prednisone: 436 reports
- Methotrexate: 435 reports
- Tylenol: 379 reports
- Gabapentin: 344 reports
- Enbrel: 344 reports
- Celebrex: 341 reports
- Oxycontin: 318 reports
- Fosamax: 312 reports
- Nasonex: 307 reports
- Sulfasalazine: 301 reports
All the drugs that are associated with Deafness neurosensory:
- Deafness neurosensory (1,422 drugs)
Common conditions associated with Deafness neurosensory:
- Rheumatoid arthritis: 432 reports
- Osteoporosis: 284 reports
- Pain: 261 reports
- Arthritis: 248 reports
- High blood pressure: 161 reports
- Sleep disorder: 148 reports
All the conditions that are associated with Deafness neurosensory:
- Deafness neurosensory (869 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on acetaminophen (the active ingredients of Tylenol) and Tylenol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Extavia and Gastroesophageal Reflux Disease - 6 seconds ago
- Famvir and Renvela drug interaction - 12 seconds ago
- Nipent and Ambien drug interaction - 19 seconds ago
- Primatene Mist vs. Flovent Diskus 50 - 21 seconds ago
- Metronidazole and Acanthamoeba Infection - 26 seconds ago
- Fexofenadine Hydrochloride and Neupogen drug interaction - 31 seconds ago
- Antiinflammatory Therapy and Substance-Induced Psychotic Disorder - 32 seconds ago
- Nourianz and Vascepa drug interaction - 36 seconds ago
- Tylenol W/ Codeine No. 3 and Viral Infection - 36 seconds ago
- Acetazolamide and Ferrous Fumarate drug interaction - 38 seconds ago